Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2492)
All Articles published online
|
Jan 7, 2007 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tillmann HL. Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 2007; 13(1): 125-140 [PMID: 17206760 DOI: 10.3748/wjg.v13.i1.125] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i1/125.htm |
| Number | Citing Articles |
| 1 |
Michael Nassal. Hepatitis B viruses: Reverse transcription a different way. Virus Research 2008; 134(1-2): 235 doi: 10.1016/j.virusres.2007.12.024
|
| 2 |
Tatiana Dupinay, Tarik Gheit, Pierre Roques, Lucyna Cova, Philippe Chevallier-Queyron, Shin-i Tasahsu, Roger Le Grand, François Simon, Geneviève Cordier, Lahcen Wakrim, Soumaya Benjelloun, Christian Trépo, Isabelle Chemin. Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island. Hepatology 2013; 58(5): 1610 doi: 10.1002/hep.26428
|
| 3 |
Naveen C. Srivastav, Neeraj Shakya, Michelle Mak, Babita Agrawal, D. Lorne Tyrrell, Rakesh Kumar. Antiviral Activity of Various 1-(2′-Deoxy-β-d-lyxofuranosyl), 1-(2′-Fluoro-β-d-xylofuranosyl), 1-(3′-Fluoro-β-d-arabinofuranosyl), and 2′-Fluoro-2′,3′-didehydro-2′,3′-dideoxyribose Pyrimidine Nucleoside Analogues against Duck Hepatitis B Virus (DHBV) and Human Hepatitis B Virus (HBV) Replication. Journal of Medicinal Chemistry 2010; 53(19): 7156 doi: 10.1021/jm100803c
|
| 4 |
Ben Berkhout, Kuan-Teh Jeang. RISCy Business: MicroRNAs, Pathogenesis, and Viruses. Journal of Biological Chemistry 2007; 282(37): 26641 doi: 10.1074/jbc.R700023200
|
| 5 |
Xavier Verhelst, Hans Orlent, Isabelle Colle, Anja Geerts, Martine De Vos, Hans Van Vlierberghe. Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2010; 22(4): 494 doi: 10.1097/MEG.0b013e3283329d13
|
| 6 |
Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken, Vito R. Cicinnati. Hepatitis B and liver transplantation: 2008 update. Reviews in Medical Virology 2009; 19(1): 7 doi: 10.1002/rmv.595
|
| 7 |
Maria Homs, Rosendo Jardi, Maria Buti, Melanie Schaper, David Tabernero, Pilar Fernandez-Fernandez, Josep Quer, Rafael Esteban, Francisco Rodriguez-Frias. HBV Core Region Variability: Effect of Antiviral Treatments on Main Epitopic Regions. Antiviral Therapy 2011; 16(1): 37 doi: 10.3851/IMP1701
|
| 8 |
Wanwisa Waiyaput, Sunchai Payungporn, Jiraphorn Issara-Amphorn, Nattanan T-Thienprasert Panjaworayan. Inhibitory effects of crude extracts from some edible Thai plants against replication of hepatitis B virus and human liver cancer cells. BMC Complementary and Alternative Medicine 2012; 12(1) doi: 10.1186/1472-6882-12-246
|
| 9 |
Min Lian, Xu Zhou, Lai Wei, Shihong Qiu, Tong Zhou, Lanfen Li, Xiaocheng Gu, Ming Luo, Xiaofeng Zheng. Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients. Virology Journal 2007; 4(1) doi: 10.1186/1743-422X-4-93
|
| 10 |
Zhigang Hu, Mei Li, Jie Liu, Lei Yu, Yifeng Xue, Yu Chen. Detection of Hepatitis B Virus Large Surface Protein Using a Time‐Resolved Immunofluorometric Assay. Journal of Clinical Laboratory Analysis 2015; 29(6): 498 doi: 10.1002/jcla.21800
|
| 11 |
Marcelle Bottecchia, Javier Garcia-Samaniego, Vincent Soriano. The implications of antiviral drugs with activity against hepatitis B virus and HIV. Current Opinion in Internal Medicine 2008; 7(1): 57 doi: 10.1097/QCO.0b013e3282f1e022
|
| 12 |
Zhenning Tan, Megan L. Maguire, Daniel D. Loeb, Adam Zlotnick. Genetically Altering the Thermodynamics and Kinetics of Hepatitis B Virus Capsid Assembly Has Profound Effects on Virus Replication in Cell Culture. Journal of Virology 2013; 87(6): 3208 doi: 10.1128/JVI.03014-12
|
| 13 |
Nikesh Patel, Sam Clark, Eva U. Weiß, Carlos P. Mata, Jen Bohon, Erik R. Farquhar, Daniel P. Maskell, Neil A. Ranson, Reidun Twarock, Peter G. Stockley. In vitro functional analysis of gRNA sites regulating assembly of hepatitis B virus. Communications Biology 2021; 4(1) doi: 10.1038/s42003-021-02897-2
|
| 14 |
Nikesh Patel, Simon J. White, Rebecca F. Thompson, Richard Bingham, Eva U. Weiß, Daniel P. Maskell, Adam Zlotnick, Eric C. Dykeman, Roman Tuma, Reidun Twarock, Neil A. Ranson, Peter G. Stockley. HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly. Nature Microbiology 2017; 2(8) doi: 10.1038/nmicrobiol.2017.98
|
| 15 |
Nattanan Panjaworayan, Sunchai Payungporn, Yong Poovorawan, Chris M Brown. Identification of an effective siRNA target site and functional regulatory elements, within the hepatitis B virus posttranscriptional regulatory element. Virology Journal 2010; 7(1) doi: 10.1186/1743-422X-7-216
|
| 16 |
P. Guo. Suppression of Interferon‐Mediated Antiviral Immunity by Hepatitis B Virus: An Overview of Research Progress. Scandinavian Journal of Immunology 2013; 78(3): 230 doi: 10.1111/sji.12086
|
| 17 |
Mauro Bendinelli, Mauro Pistello, Fabrizio Maggi, Marialinda Vatteroni. Clinical Virology Manual. 2009; : 325 doi: 10.1128/9781555815974.ch21
|
| 18 |
Mehmet Sami Serin, Ebru Bekiroglu, Serpil Polat, Aylin Dogen, Seda Tezcan, Gonul Aslan, Orhan Sezgin, Engin Altintas, Gurol Emekdas, Enver Ucbilek. Detection of hepatitis B virus polymerase gene variants associated with Lamivudine, Adefovir and Entecavir resistance and some undefined mutations isolated from chronic hepatitis B patients in the south of Turkey. Molecular Genetics, Microbiology and Virology 2010; 25(4): 178 doi: 10.3103/S0891416810040075
|
| 19 |
Fabien Abdul, Bénédicte Ndeboko, Thierry Buronfosse, Fabien Zoulim, Michael Kann, Peter E. Nielsen, Lucyna Cova, Wang-Shick Ryu. Potent Inhibition of Late Stages of Hepadnavirus Replication by a Modified Cell Penetrating Peptide. PLoS ONE 2012; 7(11): e48721 doi: 10.1371/journal.pone.0048721
|
| 20 |
Lei Li, Hong Shen, Anyi Li, Zhenhua Zhang, Baoju Wang, Junzhong Wang, Xin Zheng, Jun Wu, Dongliang Yang, Mengji Lu, Jingjiao Song. Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-214
|
| 21 |
Benedikte Serruys, Freya Van Houtte, Phebe Verbrugghe, Geert Leroux‐Roels, Peter Vanlandschoot. Llama‐derived single‐domain intrabodies inhibit secretion of hepatitis B virions in mice†. Hepatology 2009; 49(1): 39 doi: 10.1002/hep.22609
|
| 22 |
Murat Karamese, Sabiha Aydogdu, Selina Aksak Karamese, Ulku Altoparlak, Cemal Gundogdu. Preventive Effects of a Major Component of Green Tea, Epigallocathechin-3-Gallate, on Hepatitis-B Virus DNA Replication. Asian Pacific Journal of Cancer Prevention 2015; 16(10): 4199 doi: 10.7314/APJCP.2015.16.10.4199
|
| 23 |
Lihui Deng, Hong Tang. Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites. Hepatology Research 2011; 41(11): 1017 doi: 10.1111/j.1872-034X.2011.00873.x
|
| 24 |
Hui-Hua Jia, Kai-Wen Li, Qin-Yan Chen, Xue-Yan Wang, Tim J. Harrison, Shu-Jia Liang, Qing-Li Yang, Chao Wang, Li-Ping Hu, Chuang-Chuang Ren, Zhong-Liao Fang. High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China. Intervirology 2018; 61(3): 123 doi: 10.1159/000493797
|
| 25 |
Bo Kyung Kim, Seoung Ok Lim, Yun Gyu Park. Requirement of the cyclic adenosine monophosphate response element‐binding protein for hepatitis B virus replication†. Hepatology 2008; 48(2): 361 doi: 10.1002/hep.22359
|
| 26 |
Corinna M. Leistner, Stefanie Gruen-Bernhard, Dieter Glebe. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cellular Microbiology 2007; 0(0): 070810224957001 doi: 10.1111/j.1462-5822.2007.01023.x
|
| 27 |
Vincent Soriano, Eugenia Vispo, Pablo Labarga, Jose Medrano, Pablo Barreiro. Viral hepatitis and HIV co-infection. Antiviral Research 2010; 85(1): 303 doi: 10.1016/j.antiviral.2009.10.021
|
| 28 |
Hani A Masaadeh, Wail A Hayajneh, Enayat A Alqudah. Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan. World Journal of Gastroenterology 2008; 14(47): 7231-7234 doi: 10.3748/wjg.14.7231
|
| 29 |
Hüseyin Sirma, Anneke Funk, Wolfram Gerlich, Oliver Schildgen. Does pre-treatment with lamivudine prime for adefovir resistance of hepatitis B virus infection?. Journal of Antimicrobial Chemotherapy 2007; 60(2): 448 doi: 10.1093/jac/dkm199
|
| 30 |
Steven K. Herrine, Simona Rossi, Victor J. Navarro. Pharmacology and Therapeutics. 2009; : 527 doi: 10.1016/B978-1-4160-3291-5.50039-1
|
| 31 |
Di Liu, Lin Liu, Lizheng Wang, Sizhu Duan, Yanan Song, Meng Qu, Nan Gao, Jiaxin Wu, Haihong Zhang, Hui Wu, Wei Kong, Bin Yu, Xianghui Yu. Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infection. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8096
|
| 32 |
Oliver Schildgen. Novel Lamivudine Resistance. Antimicrobial Agents and Chemotherapy 2007; 51(12): 4533 doi: 10.1128/AAC.00840-07
|
| 33 |
Rachel Wilson, Damian Purcell, Hans J Netter, Peter A Revill. Does RNA interference provide new hope for control of chronic hepatitis B infection?. Antiviral Therapy 2009; 14(7): 879 doi: 10.3851/IMP1424
|
| 34 |
Fei Li, Yuxing Peng, Wenjian Xu, Guangchuang Yu, Peng LI, Xiaochen Bo, Shengqi Wang. Towards a Comprehensive HBV-Human Interaction Map. 2009 International Joint Conference on Bioinformatics, Systems Biology and Intelligent Computing 2009; : 311 doi: 10.1109/IJCBS.2009.49
|
| 35 |
Augustine Chen, Chris Brown. Distinct families ofcis-acting RNA replication elements epsilon from hepatitis B viruses. RNA Biology 2012; 9(2): 130 doi: 10.4161/rna.18649
|
| 36 |
Vincent Soriano, Eugenia Vispo, Marcelle Bottecchia, Julie Sheldon, Paula Tuma, Javier Garcia-Samaniego, Pablo Barreiro. Management of hepatitis B virus co-infection on and off antiretroviral therapy. Current HIV/AIDS Reports 2008; 5(2): 86 doi: 10.1007/s11904-008-0014-4
|
| 37 |
Gianluca Martelli, Antonella Monsignori, Mario Orena, Samuele Rinaldi. Analogues of nucleosides: synthesis of chiral pyrrolidin-2-ones or pyrrolidines-bearing nucleobases. Monatshefte für Chemie - Chemical Monthly 2014; 145(8): 1357 doi: 10.1007/s00706-014-1251-4
|
| 38 |
Jiyun Fan, Ying Wang, Hui Xiong, Xiaokui Guo, Yung-chi Cheng. Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility. Journal of General Virology 2014; 95(11): 2523 doi: 10.1099/vir.0.066886-0
|
| 39 |
Emmet B. Keeffe, Douglas T. Dieterich, Jean–Michel Pawlotsky, Yves Benhamou. Chronic Hepatitis B: Preventing, Detecting, and Managing Viral Resistance. Clinical Gastroenterology and Hepatology 2008; 6(3): 268 doi: 10.1016/j.cgh.2007.12.043
|
| 40 |
S Zhen, L Hua, Y-H Liu, L-C Gao, J Fu, D-Y Wan, L-H Dong, H-F Song, X Gao. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus. Gene Therapy 2015; 22(5): 404 doi: 10.1038/gt.2015.2
|
| 41 |
Georget Y. Reaiche, Marc F. Le Mire, William S. Mason, Allison R. Jilbert. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 2010; 406(2): 286 doi: 10.1016/j.virol.2010.07.013
|
| 42 |
S.K. Sarin, Manoj Kumar, B.C. Sharma. Response to Tseng et al.. The American Journal of Gastroenterology 2007; 102(7): 1545 doi: 10.1111/j.1572-0241.2007.01416.x
|
| 43 |
Anita Arora, Natalia Mendoza, Stephen K. Tyring. Pharmaceutical Sciences Encyclopedia. 2011; : 1 doi: 10.1002/9780470571224.pse425
|
| 44 |
Nikesh Patel, Fardokht Abulwerdi, Farzad Fatehi, Iain W. Manfield, Stuart Le Grice, John S. Schneekloth Jr., Reidun Twarock, Peter G. Stockley. Dysregulation of Hepatitis B Virus Nucleocapsid Assembly in vitro by RNA-binding Small Ligands. Journal of Molecular Biology 2022; 434(10): 167557 doi: 10.1016/j.jmb.2022.167557
|
| 45 |
Lucila Cassino, Silvina Benetti, Fabian Fay, Hugo Tanno, Jorge Quarleri. Unsuccessful therapy with adefovir and entecavir-tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine: a fourteen-year evolution of hepatitis B virus mutations. BMC Infectious Diseases 2011; 11(1) doi: 10.1186/1471-2334-11-178
|
| 46 |
J Steinmann, J Buer, T Pietschmann, E Steinmann. Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea. British Journal of Pharmacology 2013; 168(5): 1059 doi: 10.1111/bph.12009
|
| 47 |
F. Pons Renedo, J. de la Revilla Negro, J.L. Calleja Panero. Farmacolog?a del tratamiento de las infecciones por el virus C y B de la hepatitis. Interferones. Antivirales. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2008; 10(9): 555 doi: 10.1016/S0211-3449(08)73114-X
|
| 48 |
Charlotte Lepère-Douard, Maud Trotard, Jacques Le Seyec, Philippe Gripon. The First Transmembrane Domain of the Hepatitis B Virus Large Envelope Protein Is Crucial for Infectivity. Journal of Virology 2009; 83(22): 11819 doi: 10.1128/JVI.01026-09
|
| 49 |
Balasubramanian Venkatakrishnan, Sarah P. Katen, Samson Francis, Srinivas Chirapu, M. G. Finn, Adam Zlotnick, W. I. Sundquist. Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket. Journal of Virology 2016; 90(8): 3994 doi: 10.1128/JVI.03058-15
|
| 50 |
Christina Rauschhuber, Hui Xu, Felix H. Salazar, Patricia L. Marion, Anja Ehrhardt. Exploring gene‐deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice. The Journal of Gene Medicine 2008; 10(8): 878 doi: 10.1002/jgm.1207
|
| 51 |
Linda Wittkop, Alexandra Schwarz, Aurelia Cassany, Stefanie Grün-Bernhard, Mildred Delaleau, Birgit Rabe, Christian Cazenave, Wolfram Gerlich, Dieter Glebe, Michael Kann. Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation. Cellular Microbiology 2010; 12(7): 962 doi: 10.1111/j.1462-5822.2010.01444.x
|
| 52 |
María L. Cuestas, Verónica L. Mathet, José R. Oubiña, Alejandro Sosnik. Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection. Pharmaceutical Research 2010; 27(7): 1184 doi: 10.1007/s11095-010-0112-z
|
| 53 |
Oliver Schildgen. Host factors may influence response to antiviral therapy in chronic hepatitis B virus infections. Medical Hypotheses 2011; 76(3): 417 doi: 10.1016/j.mehy.2010.11.007
|
| 54 |
Teresa Santantonio, Massimo Fasano, Sandra Durantel, Luc Barraud, Manuela Heichen, Angela Guastadisegni, Giuseppe Pastore, Fabien Zoulim. Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antiviral Therapy 2009; 14(4): 557 doi: 10.1177/135965350901400416
|
| 55 |
Jean‐Pierre Gillet, Michael M. Gottesman, Mitsunori Okabe. The Liver. 2009; : 1075 doi: 10.1002/9780470747919.ch66
|
| 56 |
Zhimeng Cheng, Panpan Lin, Nansheng Cheng. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.713981
|
| 57 |
Vincent Soriano, Massimo Puoti, Marion Peters, Yves Benhamou, Mark Sulkowski, Fabien Zoulim, Stefan Mauss, Juergen Rockstroh. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008; 22(12): 1399 doi: 10.1097/QAD.0b013e3282f8b46f
|
| 58 |
Holger G. Hass, Thomas Bock, Oliver Nehls, Stephan Kaiser. Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B. Journal of Gastroenterology 2009; 44(8): 871 doi: 10.1007/s00535-009-0078-y
|
| 59 |
H. G. M. Niesters, F. Zoulim, C. Pichoud, M. Buti, F. Shapiro, N. D'Heuvaert, L. Celis, J. Doutreloigne, E. Sablon. Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment. Antimicrobial Agents and Chemotherapy 2010; 54(3): 1283 doi: 10.1128/AAC.00970-09
|
| 60 |
Olusola Anuoluwapo Akanbi, Dominik Harms, Bo Wang, Folakemi Abiodun Osundare, Olufisayo Adesina, Adeolu Sunday Oluremi, Ewean Chukwuma Omoruyi, Kai Kappert, Oluyinka Oladele Opaleye, C.-Thomas Bock. High Frequency of Drug Resistance Mutations in the HBV Genome in ART-Experienced HIV-Coinfected Patients in Southwestern Nigeria. Antiviral Therapy 2019; 24(7): 521 doi: 10.3851/IMP3333
|
| 61 |
Jianhao Cao, Junchang Zhang, Yanmeng Lu, Shuhong Luo, Jingqiang Zhang, Ping Zhu. Cryo-EM structure of native spherical subviral particles isolated from HBV carriers. Virus Research 2019; 259: 90 doi: 10.1016/j.virusres.2018.10.015
|
| 62 |
Jing You, Hutcha Sriplung, Alan Geater, Virasakdi Chongsuvivatwong, Lin Zhuang, Yun-Li Li, Hua Lei, Jun Liu, Hong-Ying Chen, Bao-Zhang Tang, Jun-Hua Huang. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients. BMC Infectious Diseases 2008; 8(1) doi: 10.1186/1471-2334-8-123
|
| 63 |
Zhenning Tan, Karolyn Pionek, Nuruddin Unchwaniwala, Megan L. Maguire, Daniel D. Loeb, Adam Zlotnick, T. S. Dermody. The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription. Journal of Virology 2015; 89(6): 3275 doi: 10.1128/JVI.03545-14
|